Therapeutic effects of monoclonal antibody g250, interferons and tumor necrosis factor, in mice with renal‐cell carcinoma xenografts

Because renal‐cell carcinoma (RCC) is considered relatively resistant to radio‐and chemotherapy, RCC patients may benefit from new treatment modalities, e.g. immunotherapy. In vitro and in vivo studies suggest that combinations of cytokines such as interferon γ or interferon a (IFN‐γ, IFN‐α) and tum...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	International journal of cancer 1994-01, Vol.56 (2), p.262-268
Hauptverfasser:	van Dijk, J., Uemura, H., Beniers, A. J. M. C., Peelen, W. P., Zegveld, S. Th, Fleuren, G. J., Warnaar, S. O., Oosterwijk, E.
Format:	Artikel
Sprache:	eng
Schlagworte:	Animals Antibodies, Monoclonal - therapeutic use Antineoplastic agents Antineoplastic Combined Chemotherapy Protocols - therapeutic use Biological and medical sciences Carcinoma, Renal Cell - pathology Carcinoma, Renal Cell - therapy Immunohistochemistry Immunotherapy Interferon Type I - administration & dosage Interferon-gamma - administration & dosage Kidney Neoplasms - pathology Kidney Neoplasms - therapy Medical sciences Mice Mice, Inbred BALB C Neoplasm Transplantation - immunology Pharmacology. Drug treatments Recombinant Proteins Transplantation, Heterologous - immunology Tumor Necrosis Factor-alpha - administration & dosage
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!